Endovascular treatment of chronic subdural hematomas
Open Access
- 29 March 2026
- journal article
- Published by Romodanov Neurosurgery Institute in Ukrainian Neurosurgical Journal
- Vol. 32 (1) , 24-39
Abstract
Objective: To evaluate the effectiveness of middle meningeal artery embolization (MMAe) in patients with chronic subdural hematoma (cSDH) based on the first 19 clinical cases performed at Mechnikov Dnipropetrovsk Regional Clinical Hospital. To clarify the indications for isolated versus combined treatment of cSDH and to assess the feasibility of the transradial approach. Materials and methods: A retrospective cohort study was conducted based on the analysis of prospectively collected data from patients with chronic subdural hematomas who underwent MMAe at I.I. Mechnikov Dnipropetrovsk Regional Clinical Hospital between March 24, 2022, and November 6, 2024. The study included 19 patients who underwent endovascular intervention, either as a standalone procedure or in combination with open surgery. Demographic data, etiological factors, clinical presentation, CT, MRI, and DSA findings were analyzed. Treatment effectiveness was assessed at 1, 3, and 6 months postoperatively. Results: According to the type of treatment, patients were divided into 3 groups: isolated MMAe — 13 patients (68.4%); primary MMAe followed by surgical drainage — 3 patients (15.8%); primary surgical evacuation followed by MMAE — 3 patients (15.8%). Traumatic cSDH was diagnosed in 12 patients (63.2%), while spontaneous cSDH occurred in 7 patients (36.8%), including two cases with mycotic aneurysms of cortical Middle Cerebral Artery (MCA) branches, which were managed with endovascular deconstructive exclusion and subsequent MMAe. One patient with chronic anemia underwent isolated MMAe. Among all patients, 5 (26.3%) were on anticoagulant/antiplatelet therapy, and hemodynamically significant carotid stenosis was identified in 3 patients (15.8%). Follow-up imaging (CT, MRI) at 6 months demonstrated clinical improvement in 100% of cases, with complete hematoma resolution in 17 patients (89.5%). Conclusions: MMAe has proven to be highly effective and safe in the management of cSDH, both as a stand-alone method and as an adjunct to conventional surgery. The transradial approach demonstrated advantages in elderly and high-risk patients, contributing to reduced hospitalization times. Furthermore, the use of OnyxTM ensured deeper penetration and more durable occlusion of pathological vessels compared to polyvinyl alcohol (PVA) particles. These findings are consistent with current global trends and confirm the promising role of MMAe in cSDH treatment.Keywords
This publication has 25 references indexed in Scilit:
- Embolization of the Middle Meningeal Artery for Chronic Subdural HematomaNew England Journal of Medicine, 2025
- Complications of Middle Meningeal Artery Embolization: A Systematic Review and Meta-AnalysisWorld Neurosurgery, 2025
- Adjunctive Middle Meningeal Artery Embolization for Subdural HematomaNew England Journal of Medicine, 2024
- Middle Meningeal Artery Embolization for Nonacute Subdural HematomaNew England Journal of Medicine, 2024
- Multidisciplinary consensus-based statement on the current role of middle meningeal artery embolization (MMAE) in chronic SubDural hematoma (cSDH)Brain and Spine, 2024
- Clinical practice guidelines for the care of patients with a chronic subdural haematoma: multidisciplinary recommendations from presentation to recoveryBritish Journal Of Neurosurgery, 2024
- Middle meningeal artery embolization for chronic subdural hematoma: an effective treatment with a bright futureJournal of NeuroInterventional Surgery, 2024
- Transradial versus transfemoral access for posterior circulation endovascular intervention: A systematic review and meta-analysisClinical Neurology and Neurosurgery, 2023
- Middle meningeal artery embolization with subdural evacuating port system for primary management of chronic subdural hematomasNeurosurgical Review, 2021
- DynaCT Enhancement of Subdural Membranes After Middle Meningeal Artery Embolization: Insights into PathophysiologyWorld Neurosurgery, 2020